Packaging Gateway

Return packaging works: codes that scan, seals that hold

Build return packaging for two journeys: scannable codes, secure seals and right-sized mono-material formats with simple ...

Novartis Pharma AG: Novartis Phase III trial for next-generation malaria treatment KLU156 ...

Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...